Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
29th January 2021 | Anirvan Ghosh | 250,000 | Grant/award etc. | $0.00 | |
16th December 2020 | Nathaniel E David | 1,700,000 | Open or private sale | $5.24 | $8,908,000.00 |
13th September 2020 | Anirvan Ghosh | 300,000 | Grant/award etc. | $0.00 | |
13th September 2020 | Lynne Marie Sullivan | 240,000 | Grant/award etc. | $0.00 | |
13th September 2020 | Jamie Dananberg | 240,000 | Grant/award etc. | $0.00 | |
13th September 2020 | Alexander Azoy | 135,000 | Grant/award etc. | $0.00 | |
9th September 2020 | Ii Robert C. Goeltz | 5,000 | Open or private purchase | $21.57 | $107,848.50 |
22nd June 2020 | Ii Robert C. Goeltz | 2,483 | Payment by withholding | $9.67 | $24,010.61 |
22nd June 2020 | Jamie Dananberg | 2,483 | Payment by withholding | $9.67 | $24,010.61 |
22nd June 2020 | Nathaniel E David | 2,483 | Payment by withholding | $9.67 | $24,010.61 |
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
Unity Biotechnology, Inc. operates as a biotechnology company. The company was founded by Nathaniel David, Jan van Deursen, Judith Campisi and Daohong Zhou in March 2009 and is headquartered in Brisbane, CA.
24th February 2021
27th December 2020
16th December 2020